A detailed history of Abound Wealth Management transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Abound Wealth Management holds 10 shares of CPRX stock, worth $227. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 12 16.67%
Holding current value
$227
Previous $186,000 6.99%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$15.19 - $21.35 $30 - $42
-2 Reduced 16.67%
10 $199,000
Q2 2024

Aug 09, 2024

SELL
$14.68 - $16.92 $73 - $84
-5 Reduced 29.41%
12 $186,000
Q4 2023

Aug 08, 2024

BUY
$11.78 - $17.29 $200 - $293
17 New
17 $286,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.34B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Abound Wealth Management Portfolio

Follow Abound Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abound Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Abound Wealth Management with notifications on news.